Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Assets (2016 - 2025)

CorMedix's Return on Assets history spans 12 years, with the latest figure at 0.17% for Q4 2025.

  • For Q4 2025, Return on Assets rose 37.0% year-over-year to 0.17%; the TTM value through Dec 2025 reached 0.17%, up 37.0%, while the annual FY2025 figure was 0.29%, N/A changed from the prior year.
  • Return on Assets for Q4 2025 was 0.17% at CorMedix, down from 0.32% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.32% in Q3 2025 and bottomed at 0.8% in Q2 2024.
  • The 5-year median for Return on Assets is 0.45% (2021), against an average of 0.35%.
  • The largest annual shift saw Return on Assets dropped -15bps in 2023 before it surged 105bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.42% in 2021, then dropped by -15bps to 0.48% in 2022, then decreased by -13bps to 0.54% in 2023, then skyrocketed by 65bps to 0.19% in 2024, then soared by 191bps to 0.17% in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Return on Assets are 0.17% (Q4 2025), 0.32% (Q3 2025), and 0.25% (Q2 2025).